0 citations
Activity of high-dose toremifene plus cisplatin in platinum-treated non-small-cell lung cancer: a phase II California Cancer Consortium Trial
Cancer Chemotherapy and Pharmacology2001Vol. 48(1), pp. 22–28
Citations Over TimeTop 19% of 2001 papers
Primo Lara, David R. Gandara, Jeff Longmate, Paul H. Gumerlock, Derick Lau, Martin J. Edelman, Regina Gandour‐Edwards, Philip C. Mack, Valerie K. Israel, James Raschko, Paul Frankel, Edith A. Perez, Heinz Josef Lenz, James Doroshow
Related Papers
- → Effects of the Antiestrogens Tamoxifen, Toremifene, and ICI 182,780 on Endometrial Cancer Growth(1998)140 cited
- → The Effect of Selective Estrogen Receptor Modulators (SERMs) on the Tamoxifen Resistant Breast Cancer Cells(2011)35 cited
- → Questions about Tamoxifen and the Future Use of Antiestrogens(1998)15 cited
- → Chinese breast cancer patients with CYP2D6*10 mutant genotypes have a better prognosis with toremifene than with tamoxifen(2021)5 cited
- [Breast cancer--tamoxifen and tamoxifen analogues for the treatment of breast cancer].(1994)